Deutsch - Impulse Dynamics
  • Home
  • Patienten
  • Medizinische Fachkräfte
    • Indikationen gemäß CE-Kennzeichnung & Patientenselektion
    • Verfahren und Wirkungsweise
    • Publikationen
    • Gebrauchsanweisun-gen und Handbücher
  • Unternehmen
    • News
    • Governance – Grundsätze der Unternehmens-führung
    • Informations-quellen
    • Karriere
    • Kontakt
  • Einen Arzt finden
  • Region
    • US
    • DE
    • Global
Select Page

Impulse Dynamics Announces First Implants Of Optimizer Smart Mini

by Impulse Dynamics | May 10, 2022 | News and Events, Press Releases

PRESS RELEASE Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing...

IMPULSE DYNAMICS LAUNCHES OPTIMIZER SMART MINI

by Impulse Dynamics | Apr 29, 2022 | News and Events, Press Releases

PRESS RELEASE Smaller, Smarter, Long-lasting Device Gives Patients a Reason To Believe There Is a Tomorrow MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...

IMPULSE DYNAMICS ANNOUNCES 7,000TH PATIENT TREATED WITH CCM® REINFORCING SIGNIFICANT CLINICAL EXPERIENCE

by Impulse Dynamics | Apr 26, 2022 | News and Events, Press Releases

PRESS RELEASE CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...

IMPULSE DYNAMICS’ QUALITY MANAGEMENT SYSTEM RECEIVES CERTIFICATION UNDER EUROPEAN UNION MEDICAL DEVICE REGULATION

by Impulse Dynamics | Mar 22, 2022 | News and Events, Press Releases

PRESS RELEASE Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart...

IMPULSE DYNAMICS ANNOUNCES FIRST PATIENT ENROLLED IN AIM HIGHer — IMPLANTABLE DEVICE TRIAL TO TREAT HEART FAILURE IN HIGHER EF POPULATION

by Impulse Dynamics | Mar 14, 2022 | News and Events, Press Releases

PRESS RELEASE Trial Evaluates FDA-Designated BreakthroughTherapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today...
« Older Entries
Next Entries »

Recent Posts

  • Sync Global IT DE
  • TEST SYNC POST MM de
  • Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy
  • Late-breaking Results Show Efficacy for CCM in Patients With HFpEF
  • Impulse Dynamics Completes $101M Financing Round

Recent Comments

  • 1amphibious on Impulse Dynamics Announces Chief Financial Officer Transition

Archives

  • August 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • February 2021
  • January 2021
  • April 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • March 2019
  • May 2018
  • December 2017
  • August 2017
  • May 2017
  • March 2017
  • September 2016
  • May 2016
  • March 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • January 2015
  • December 2014

Categories

  • News and Events
  • Press Releases
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Like most websites on the internet, this website uses cookies. By using our website, you agree to our Cookie Policy. I Accept